Literature DB >> 29072569

Comprehension and construct validity of the Visual Prostate Symptom Score (VPSS) by men with obstructive lower urinary tract symptoms in rural Africa.

Lynn Stothers1, Andrew Macnab2, Francis Bajunirwe3, Sharif Mutabazi4, Catherine Lobatt5.   

Abstract

INTRODUCTION: The Visual Prostate Symptom Score (VPSS) is an image-based interpretation of the International Prostate Symptom Score (IPSS) intended to quantify frequency, nocturia, weak stream, and quality of life (QoL) in a literacy-independent manner.
METHODS: Ugandan men presenting with lower urinary tract symptons (LUTS) to a rural clinic completed VPSS and IPSS independently and then with assistance. They verbally interpreted VPSS images, rated question usefulness, and suggested improvements. Responses between word-based and image-based measures were compared (Student's T, Fisher's exact, and Spearman's correlation tests).
RESULTS: One hundred thirty-two scores from 33 men (mean age: 61 years, range 28-93; education: no schooling 20%, grades 1-4 62%, 5-7 9%, 8-12 9%). Correlation between IPSS and VPSS scores was positive (r=0.70), as was that between the individual irritative, obstructive, and QoL questions. Independent of education, the weak stream image was best-recognized. Likert scale measures indicated this was the most useful image, followed by daytime frequency. Nocturia and QoL images were rated as less clear, with explanation required before most understood that QoL facial expression images reflected overall LUTS impact. Improvements suggested included: increased image size for frequency and nocturia pictograms, increased black/white contrast for nocturia, and addition of an image to allow reporting of urgency.
CONCLUSIONS: In a population with little formal education, there was positive correlation between IPSS and VPSS, with inherent recognition best for weak stream and worst for QoL images. Increased image clarity and an additional image for urgency will enhance the global utility of the VPSS for men to report symptoms of LUTS.

Entities:  

Year:  2017        PMID: 29072569      PMCID: PMC5698017          DOI: 10.5489/cuaj.4589

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  13 in total

1.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

2.  One-year follow-up of 2829 patients with moderate to severe lower urinary tract symptoms treated with alfuzosin in general practice according to IPSS and a health-related quality-of-life questionnaire. BPM Group in General Practice.

Authors:  B Lukacs; J C Grange; D Comet
Journal:  Urology       Date:  2000-04       Impact factor: 2.649

3.  International prostate symptom score: really appreciated by all patients or not?

Authors:  Metin Îshak Oztürk; Orhan Koca; Muzaffer Oğuz Keleş; Mustafa Güneş; Cevdet Kaya; Muhammet Îhan Karaman
Journal:  Urol J       Date:  2011       Impact factor: 1.510

4.  An assessment of the comprehension of the American Urological Association Symptom Index.

Authors:  S A MacDiarmid; T C Goodson; T M Holmes; P R Martin; R B Doyle
Journal:  J Urol       Date:  1998-03       Impact factor: 7.450

5.  Prospective comparison of a new visual prostate symptom score versus the international prostate symptom score in men with lower urinary tract symptoms.

Authors:  Chris L E van der Walt; Chris F Heyns; Adam E Groeneveld; Rachel S Edlin; Stephan P J van Vuuren
Journal:  Urology       Date:  2011-05-07       Impact factor: 2.649

6.  Development and validation of an Arabic version of the International Prostate Symptom Score.

Authors:  Fayez T Hammad; Mohammed A Kaya
Journal:  BJU Int       Date:  2009-10-26       Impact factor: 5.588

7.  Incidence of visual loss in rural southwest Uganda.

Authors:  S M Mbulaiteye; B C Reeves; F Mulwanyi; J A G Whitworth; G Johnson
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

8.  The influence of patient education level on the International Prostatic Symptom Score.

Authors:  N R Netto Júnior; M L de Lima
Journal:  J Urol       Date:  1995-07       Impact factor: 7.450

9.  Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?

Authors:  M J Barry; W O Williford; Y Chang; M Machi; K M Jones; E Walker-Corkery; H Lepor
Journal:  J Urol       Date:  1995-11       Impact factor: 7.450

10.  Comparison between visual prostate symptom score and international prostate symptom score in males older than 40 years in rural Indonesia.

Authors:  Andika Afriansyah; Yogi Ismail Gani; Hari Nusali
Journal:  Prostate Int       Date:  2014-08-21
View more
  4 in total

1.  Family Physician's Educational Interview with Patients Helps in Early Recognition of Lower Urinary Tract Symptoms.

Authors:  Ana Lesac Brizić; Vladimir Mozetič
Journal:  Int J Gen Med       Date:  2021-12-14

2.  How Do Patients Understand Questions about Lower Urinary Tract Symptoms? A Qualitative Study of Problems in Completing Urological Questionnaires.

Authors:  Florine W M Schlatmann; Michael R van Balken; Andrea F de Winter; Igle-Jan de Jong; Carel J M Jansen
Journal:  Int J Environ Res Public Health       Date:  2022-08-05       Impact factor: 4.614

3.  Can new, improvised Visual Prostate Symptom Score replace the International Prostate Symptom Score? Indian perspective.

Authors:  K N Sanman; Ranjit Shetty; Rajeshkumar Reddy Adapala; Santosh Patil; Gg Laxman Prabhu; P Venugopal
Journal:  Indian J Urol       Date:  2020-04-07

4.  Luts-V: A new simplified score for assessing lower urinary tract symptoms in men.

Authors:  Caroline Santos Silva; Ueslei Menezes de Araujo; Mateus Andrade Alvaia; Kátia Santana Freitas; Taciana Leonel Nunes Tiraboschi; Cristiano Mendes Gomes; José de Bessa
Journal:  Int Braz J Urol       Date:  2021 May-Jun       Impact factor: 1.541

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.